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Abstract
Background: In many studies investigating measures to attenuate the hemodynamic and humoral
stress response during induction of anaesthesia, primary attention was paid to the period of
endotracheal intubation since it has been shown that even short-lasting sympathetic cardiovascular
stimulation may have detrimental effects on patients with coronary artery disease. The aim of this
analysis was, however, to identify the influencing factors on high catecholamine levels before
induction of anaesthesia.
Methods: Various potential risk factors that could impact the humoral stress response before
induction of anaesthesia were recorded in 84 males undergoing coronary aortic bypass surgery, and
were entered into a stepwise linear regression analysis. The plasma level of norepinephrine
measured immediately after radial artery canulation was chosen as a surrogate marker for the
humoral stress response, and it was used as the dependent variable in the regression model.
Accordingly, the mean arterial blood pressure, heart rate and the calculated pressure-rate product
were taken as parameters of the hemodynamic situation.
Results: Stepwise regression analysis revealed that the oral administration of low-dose clonidine
(mean dose 1.75 µg·kg-1) on the morning of surgery was the only significant predictor (p = 0.004)
of the high variation in preoperative norepinephrine plasma levels. This intervention decreased
norepinephrine levels by more than 40% compared to no clonidine administration, from 1.26 to
0.75 nmol·l-1. There was no evidence for dose-responsiveness of clonidine. All other potential
predictors were removed from the model as insignificant (p > 0.05). The use of beta-blocker, ace-
inhibitors, ejection fraction, and body mass index were significant determinants for the
hemodynamic situation (heart rate, mean arterial pressure, pressure rate product) of the patient
during the pre-induction period.
Conclusion: The oral administration of clonidine is the only significant predictor for the observed
variation of norepinephrine levels during the preoperative period. Lack of significant dose
responsiveness suggests that even a low dose of the drug can attenuate the preoperative stress
response and thus is recommended in cardiovascular high risk patients.
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Background
There is increasing evidence that sympathetic nervous sys-
tem mediated cardiovascular stimulation with increased
catecholamine blood levels is the principal mechanism
responsible for perioperative tachycardia and hyperten-
sion, myocardial ischemia and infarction [1-3]. Even
short-lived changes may have detrimental effects on the
coronary circulation of high-risk patients, with higher
rates of morbidity and lethality [4,5]. Thus, many studies
have concentrated on the stressful stimulus of endotra-
cheal intubation, and a number of pharmacological
attempts have been used to attenuate the hemodynamic
response, including the use of high doses of opioids, α2-
adrenergic receptor agonists, β-adrenergic blocking drugs
or other antihypertensive drugs [3,4,6-19].
However, little attention has been paid to the stress
response of cardiac high risk patients when entering the
operating area, during initiation of routine monitoring,
and finally during awake venous and arterial canulation.
Especially the latter procedure can cause significant dis-
comfort for patients even when performed under local
anaesthesia [20]. In several trials a high inter-individual
variation of pre-induction norepinephrine levels, heart
rate and blood pressure could be noticed [21]. Thus, this
observational analysis was performed in patients under-
going coronary aortic bypass surgery (CABG-surgery) in
order to identify patients at high risk for increased sym-
pathoadrenergic stress response during the immediate
preoperative period using norepinephrine levels and the
hemodynamic status as surrogate measures.
Methods
After Ethics Committee approval was obtained, patients
gave their written and informed consent. Eighty-four con-
secutive male patients undergoing CABG-surgery were
enrolled into this observational study. The only exclusion
criterion was emergency operation.
Due to the observational character of the study, drugs
administered preoperatively (including clonidine) were
given at the discretion of the anaesthetist performing the
preoperative examination. Each patient received an oral
premedication with clorazepate 20 mg in the evening
before surgery and in the morning of surgery. In about
half of the patients, benzodiazepine premedication was
combined with clonidine 75–300 µg. Patients were main-
tained on their regular cardiac and antihypertensive med-
ication up to the day of surgery but all inhibitors of
platelet aggregation were discontinued 3–7 day preopera-
tively. After arrival at the operating theatre an i.v. line was
initiated and 500 ml hydroxyethyl-starch (10%, 200000
Dalton) was infused. A 12-lead channel ECG with an
automatic ST-segment analysis, oxygen saturation and
invasive blood pressure monitoring were connected to the
patients. A radial artery catheter was then inserted after
local anaesthesia with 1 ml mepivacaine 1%. Heart rate
(HR) and mean arterial blood pressure (MAP) were
recorded every 15 seconds online using a Laptop compu-
ter connected to a Solar 9500 monitor (General Electrics,
USA). HR and MAP were multiplied to receive the pres-
sure-rate product (PRP). These variables were used as a
measure of the hemodynamic stress response. To deter-
mine humoral stress response, an arterial blood sample
for the measurement of norepinephrine plasma level was
taken immediately after placing the radial artery catheter
(this measurement was the main outcome of the study)
and 5, 15, and 60 minutes after endotracheal intubation
was performed (these measurements were used in an
additional explorative analysis, see figure 1). 10 ml plastic
lithium-heparin tubes were used for this purpose. Speci-
mens were placed on ice immediately after sampling,
spun in a centrifuge for 20 minutes and plasma was sepa-
rated and stored at -70°C pending analysis. Plasma nore-
pinephrine levels were determined by high-performance
liquid chromatography (HPLC) with electrochemical
detection (Millipore, Billerica, Mass. USA). The lower
limit of detection for norepinephrine was 0.018–0.024
nmol·l-1 and the same-day coefficient of variation for
norepinephrine measurements determined by repeated
measures of a standardized probe was 3%.
General anaesthesia was standardized. After administra-
tion of midazolam 0.05 mg·kg-1  and a three minute
period of preoxygenation, anaesthesia was induced using
a continuous infusion of propofol (10 mg·kg-1.h-1) and
sufentanil (10 µg.kg-1.h-1). After loss of consciousness pro-
pofol was reduced to 3 mg·kg-1.h-1 and sufentanil to 1.5
Norepinephrine levels in patients with and without clonidine  premedication Figure 1
Norepinephrine levels in patients with and without clonidine 
premedication.
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µg·kg-1.h-1. Endotracheal intubation was performed after
administration of pancuronium bromide 0.1 mg·kg-1.
To allow comprehensive analysis of potential factors asso-
ciated with a reduced stress response, the following data
were recorded prospectively:
• Age
• Bodyweight
• Height
• Body mass index (BMI)
• Clorazepate dose per kilogram bodyweight
• Clonidine (yes – no)
• Clonidine per kilogram bodyweight
• Time from morning premedication until observational
period
• Inhibitors of the angiotensine converting enzyme sys-
tem (ace-inhibitors)
• Beta-blocking drugs
• Calcium antagonists
• Angiotensin-2 receptor inhibitors
• Left ventricular ejection fraction (EF)
• Number of affected vessels
Statistical analysis
A power analysis had revealed that 80 patients provide a
power of more than 95% to detect an R2 of 0.3 and higher,
attributed to 14 independent variables using an F-test
with a significance level of 0.05. All potential relevant fac-
tors were subjected to a stepwise linear regression analysis
using a backward technique. In each step the least signifi-
cant factor was eliminated when F was lower than 3.96.
The quality of the regression model was judged using the
Durbin-Watson statistic (a value between 0 and 4 indicat-
ing the amount of autocorrelation within the model with
an optimum of 2.0), and by checking if the standardized
residuals are normally distributed. All calculations were
performed using SPSS 11.0 for Windows. All continuous
data are presented as mean and standard deviation when
normally distributed and as median (25th–75th percentile)
when normal distribution had to be rejected using the
Kolmogorov-Smirnov-test.
Results
Stepwise regression analysis revealed that the single
administration of low-dose clonidine (mean dose 1.75
µg·kg-1) on the morning of surgery was the only signifi-
cant predictor (p = 0.004) of the high variation in preop-
erative norepinephrine plasma levels. This intervention
decreased norepinephrine levels by 40% compared to no
clonidine administration (from 1.26 to 0.75 nmol·l-1). In
this analysis, the dichotomous variable (clonidine admin-
istration: yes-no) was a better predictor for the norepine-
phrine levels than variables including the clonidine dose
(absolute dose or dose per body weight), indicating that
our data provide no evidence for a strong dose-respon-
siveness of clonidine in this context.
All other of the investigated factors (see methods) were
removed from the regression model as not significant. The
two factors that were eliminated with a p < 0.1 during the
last but one and during the final step were body mass
index (removed in step 11 with a p = 0.064) and age
(removed in step 12 with a p = 0.076). Both factors were
associated with increased norepinephrine levels.
The overall quality of the regression model was excellent.
The Durbin-Watson coefficient was 2.04 (very near to the
optimum of 2.0) and the standardized residuals were nor-
mally distributed.
For mean arterial blood pressure, heart rate and the calcu-
lated pressure rate product, however, preoperative cloni-
dine administration was not an influencing factor.
For the mean arterial pressure (MAP), a higher ejection
fraction (EF) was a statistically significant predictor (p =
0.024). Each 10% increase of EF was associated with a 2.7
mmHg higher MAP. Administration of an ace-inhibitor
was the second predictor in the final model of MAP (p =
0.03). These patients had a 7.5 mmHg lower MAP than
patients without ace-inhibitors.
For heart rate (HR) there were three significant predictors
that remained in the model. Administration of beta-
blockers and ace-inhibitors were both associated with a
decreased HR (p = 0.004). Each of them decreased HR
between 6–7 beats per minute (bpm). Additionally, a
higher BMI was associated with a 1.3 bpm higher HR per
kg·m-2 (p = 0.001).
Since the PRP is the product of HR and MAP, it is not sur-
prising that similar variables contributed to its prediction.
These were the administration of beta-blockers (p =
0.017) and ace-inhibitors (p = 0.004), each of them
reducing the PRP, whereas the EF was associated with an
increase in PRP (p = 0.014).BMC Anesthesiology 2004, 4:7 http://www.biomedcentral.com/1471-2253/4/7
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No patient had signs of cardiac ischemia on arrival at the
operating theatre until induction of anaesthesia (defined
as ST-T change > 0.1 mV in any ECG lead). There were no
major adverse events during the entire induction period
and surgery.
Discussion
The  α2-adrenergic receptor agonist clonidine acts by
decreasing central sympathetic nervous system activity in
all hyperadrenergic situations. In addition to its sedative,
anxiolytic, analgesic and antihypertensive properties
[6,22] it has shown to improve congestive heart failure, to
optimize the myocardial oxygen supply / demand ratio in
ischemic heart disease [23,24] and to reduce attacks of
angina pectoris [25,26].
In many investigations attention has been drawn to the
stressful stimulus of endotracheal intubation [3,4,6-19],
as it has been shown that even short-lasting sympathetic
cardiovascular stimulation may have detrimental effects
on the coronary circulation of patients with coronary
artery disease (CAD), with higher rates of morbidity and
lethality [4,5], However, little emphasis has been paid to
the preoperative period where patients may be stressed by
or because of the upcoming procedure. Furthermore,
transfer to the operating theatre, initiation of routine
monitoring, and venous and arterial canulations are stres-
sors for the patients. In this context it is certainly a draw-
back of our study that we did not record the level of
preoperative sedation or anxiolysis using clinical meas-
urements on appropriate scales. Instead of this, only a
rough judgment was made (awake versus asleep but rous-
able) that did not allow a valid analysis of the data. Previ-
ous data, however, have shown potent anxiolytic and
sedative properties of the drug [27].
Thus, it was the major aim of this observational study to
identify factors that might contribute either to increased
humoral stress or that might help to attenuate this
response.
Our results show, that a single application of low dose
oral clonidine was the only factor that was associated with
significantly decreased norepinephrine levels on arrival at
the pre-induction area. The question that arises from this
Table 1: Patients' demographic data and preoperative condition. Data are presented for all 84 patients that were included in the study, 
and separately for those patients receiving clonidine and those without oral clonidine premedication. Values are expressed as mean ± 
standard deviation, median (25th–75th percentile), or n = (%).
All patients Patients with clonidine morning 
premedication
Patients without clonidine morning 
premedication
n = 84 n = 42 n = 42
Age (years) 66 ± 9 65 ± 9 67 ± 8
Bodyweight (kg) 82 ± 10 82 ± 11 82 ± 10
Height (cm) 173 ± 6 173 ± 6 173 ± 5
BMI (kg · m-2) 27.3 ± 3.1 27.3 ± 3.2 27.4 ± 3.0
EF (%) 62 ± 14 61 ± 13 63 ± 16
Affected vessels (n = / %)
n = 1 3 (4%) 0 (0%) 3 (7%)
n = 2 16 (19%) 9 (21%) 7 (17%)
n = 3 64 (76%) 33 (79%) 31 (74%)
n = 4 1 (1%) 0 (0%) 1 (2%)
Pre-treated with (n= / %)
ace-inhibitors 43 (51%) 17 (40%) 26 (62%)
Beta-blockers 55 (65%) 26 (62%) 29 (69%)
Calcium-antagonists 12 (14%) 5 (12%) 7 (17%)
Clonidine dose (n= / %)
75 µg8  ( 1 9 % )
150 µg n/a 33 (79%) n/a
300 µg1  ( 2 % )
Time from morning premedication 
until observational period (hours)
1.0 (0.5–4.5) 2.5 (0.5–5.0) 1.0 (0.5–4.5)
Heart rate [bpm] 66 ± 11 66 ± 10 66 ± 12
Mean arterial blood pressure [mmHg] 102 ± 16 100 ± 15 104 ± 17
Pressure rate product [mmHg·bpm] 6750 ± 1640 6660 ± 1600 6850 ± 1690
Plasma norepinephrine level (nmol·l-1) 1.00 ± 0.82 0.75 ± 0.48 1.26 ± 1.00BMC Anesthesiology 2004, 4:7 http://www.biomedcentral.com/1471-2253/4/7
Page 5 of 6
(page number not for citation purposes)
observation is, if this is simply an association (or statisti-
cally spoken a co-linearity between other protective fac-
tors) or if clonidine premedication is the cause for lower
norepinephrine levels. In our opinion the latter is the
case. Firstly, there were no differences considering any
other variables between those patients who had received
clonidine and those who had not (see table 1). Thus, it is
unlikely that other factors were responsible for the
reduced norepinephrine levels. Secondly, there is good
evidence from the literature that clonidine is a powerful
drug that attenuates stress response of various causes
[3,4,6-19].
However, it is interesting to notice that the mean dose
administered to our patients (1.75 µg·kg-1) was low com-
pared to all other trials. Data concerning the appropriate
dose of clonidine to attenuate the stress response to intu-
bation vary considerably between 0.625 and 10 µg·kg-1.
For example, one trial demonstrated that clonidine 0.625
and 1.25 µg·kg-1 i.v. were sufficient to attenuate pressure
response to laryngoscopy and intubation [28], whereas in
another one [19] evaluating the dose-response effects to
laryngoscopy and intubation, 2 µg·kg-1 clonidine i.v. was
equally effective as placebo, and only 4 and 6 µg·kg-1 sig-
nificantly attenuated hemodynamic and adrenergic reac-
tions in an equal manner. It could also be shown that 4 or
6 µg·kg-1 were necessary to reduce norepinephrine levels
before induction of anaesthesia, however 2 µg·kg-1 where
not sufficient in this setting [19].
In our trial as well as in all other studies with even much
higher doses, clonidine was well tolerated and did not
produce any adverse hemodynamic effects.
In our analysis there was no strong evidence for a dose
responsiveness of orally administered clonidine. First, in
the regression model catecholamine levels could better be
predicted by the dichotomous variable and second, there
was only a weak correlation between the weight adjusted
clonidine dose on the one hand and norepinephrine lev-
els on the other hand (Pearson's correlation coefficient
was -0.31, Spearman's rank correlation coefficient was -
0.30). Furthermore, a post-hoc comparison between the
patients receiving either 75 or 150µg clonidine did not
show relevant differences (p = 0.91 using the Mann-Whit-
ney U-test).
Higher age and higher body mass index showed a non-sig-
nificant tendency to increase the catecholamine concen-
tration. No other of the investigated factors (body weight,
height, time from morning premedication until observa-
tional period, benzodiazepine dose per kilogram body-
weight, ace-inhibitors, beta-blocking drugs, calcium
antagonists, EF, number of affected vessels) had statisti-
cally significant impact on norepinephrine levels.
An explorative post-hoc analysis of the impact of cloni-
dine premedication (none versus any dose) and clonidine
dose on norepinephrine levels during the entire induction
period proves the results of the main analysis. There was a
pronounced reduction of norepinephrine plasma levels
after induction of general anaesthesia with lower values in
the clonidine-group. However, a statistically significant
interaction term (p = 0.012) suggests that the fall of nore-
pinephrine levels are more marked in the untreated group
and thus mainly caused by induction of general anaesthe-
sia rather than effects of clonidine (figure 1).
Conclusion
This observational trial demonstrates that patients under-
going coronary artery bypass graft surgery have a great var-
iation of norepinephrine levels when entering the
operating theatre. We could identify oral clonidine pre-
medication as the only predictor for increased humoral
stress response. There was no strong evidence for a dose
dependency, indicating that even small doses, like 75–
150 µg attenuate the humoral stress response before coro-
nary artery bypass graft surgery. Clonidine did not have a
negative impact on hemodynamic parameters.
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